Hepatocellular Carcinoma
Transcatheter arterial chemoembolization rarely aggravates hepatitis B-related liver disease
Published in Hepatitis Weekly, November 7th, 2005
"Systemic chemotherapy may lead to immune suppression and possible reactivation of hepatitis B virus (HBV), suggesting prophylactic antiviral therapy in cancer patients with HBV. Transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) is not a systemic chemotherapy, but has been partially associated with HBV reactivation," investigators in South Korea report.
"The aim of this study was to evaluate whether TACE aggravates HBV hepatitis in patients with HBV-related HCC. Eighty-nine patients with HBV-related HCC were studied...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-11-07)
More Articles from Hepatitis Weekly
- Diagnostics
Fluorescent nanoparticle labels facilitate rapid screening for hepatitis B infection - Hematology
Patient host factors prevent GB virus C, hepatitis, and HIV infection in exposed hemophiliacs - Hepatitis C Therapy
Interleukin-10 receptor blockade may augment therapy targeting hepatitis C - Vaccine Safety
Limulus amoebocyte lysate assay detects endotoxin in hepatitis B virus vaccine - Adverse Drug Reactions
Mitochondrial permeability transition main effect of mitochondrial uncoupling, ROS is secondary - Analgesia
Pain scores look similar in patients given different liver biopsy procedures - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
